In human breast cancer, miR-21 upregulates the EMT, the PI3K/ATK signaling pathway, the anti-apoptotic pathway and induces proliferation by targeting very well-characterized tumors suppressors such as PTEN, TPM1, and PDCD4 [121,122,129,130]. This evidence concerns the gene PTEN and breast carcinoma.